Synthesis and antimicrobial activity of some new quinazolin-4(3H)-one derivatives

Pharmaceutical Biology

Volumn 46, Issue 10-11, 2008, Pages 751-756

  Alafeefy, Ahmed M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antimicrobial activity; Quinazolin 4(3H) one; Synthesis; Thioureide

Indexed keywords

1 ACYL 4 [6 IODO 4 OXO 2 PHENYLQUINAZOLIN 3(4H) YL]THIOSEMICARBAZIDE DERIVATIVE; 4 [6 IODO 4 OXO 2 PHENYLQUINAZOLIN 3(4H) YL]THIOSEMICARBAZIDE; 6 IODO 2 PHENYLQUINAZOLIN 4(3H) ONE DERIVATIVE; AMPICILLIN; CLOTRIMAZOLE; QUINAZOLIN 4(3H) ONE DERIVATIVE; QUINAZOLINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BROTH DILUTION; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STANDARD;

CANDIDA ALBICANS; PSEUDOMONAS AERUGINOSA;

EID: 57649202225     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200802315907     Document Type: Article

References (18)

1. Apfel C, Banner DW, Bur D, Dietz M, Hubschwerlen C, Locher H, Marlin F, Masciadri R, Pirson W, Stalder H (2001): 2-(2-Oxo-1,4-dihydro-2H-quinazoli-3-yl) - and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda 6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-actamides as potent and selective peptide deformylase inhibitors. J Med Chem 44: 1847-1852.
2. Berber I, Cokmus C, Atalan E (2003): Comparison of Staphylococcus spp. Cellular and extracellular proteins. Mikrobiologia 72: 54-59.
3. Carpenter CF, Champers HF (2004): Daptomycin: Another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis 38: 994-1000.
4. Chang Z, Babiuk LA, Hu J (2007): Therapeutic and prophylactic potential of small interfering RNAs against severe acute respiratory syndrome: Progress to date. Bio Drugs 21: 9-15.
5. Chenard BL, Welch WM, Blake JF, Butler TW, Reinhold A, Ewing FE, Menniti FS, Pagnozzi MJ (2001): Quinazolin-4-one α-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid (AMPA) receptor antagonists: Structure-activity relationship of the C-2 side chain tether. J Med Chem 44: 1710-1717.
6. Gary WWK, Ting LF (2007): Bird flu: Lessons from SARS. Paediatr Respir Rev 8: 171-176.
7. Grunder G, Zysset-Aschmann Y, Vollenweider F, Maier T, Krähenbühl S, Drewe J (2006): Lack of pharmacokinetic interaction between Linezolid and antacid in healthy volunteers. Antimicrob Agents Chemother 50: 68-72.
8. Guang-Fang X, Bao-An S, Pinaki SB, Song Y, Pei-Quan Z, Lin-Hong J, Wei X, De-Yu H, Ping L (2007): Synthesis and antifungal activity of novel S-substituted 6-fluoro-4-alkyl(aryl)thioquinazoline derivatives. Bioorg Med Chem 15: 3768-3774.
9. Gürsoy A, Ilhan N (1995): Synthesis and antimicrobial evaluation of new quinazoline derivatives. Farmaco 50: 559-663.
10. Jiang JB, Hesson DP, Dusk BA, Dexter DL, Kang GJ, Hamel E (1990): Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization. J Med Chem 33: 1721-1728.
11. Patrick PM, Ellen BJ, Michael AP, Fred CT, Robert HY (1995): Clinical laboratory standards. In: Wood GL, Washington ed., Manual of Clinical Microbiology. Washington, DC, Am Soc Microbiol, pp. 273-286.
12. Prasad MR, Pathak US, Rao AR (2000): Synthesis and analgesic activity of some novel 2-substituted 1,3,4-thiadiazolo[2,3-b]disubstituted/tetrasubstituted thieno[3,2-e]pyrimidin-5(4H)-ones. Arzneim-Forsch/Drug Res 50: 904-909.
13. Raffa D, Daidone G, Schillaci D, Maggio B, Plescia F (1999): Synthesis of new 3-(3-phenyl-isoxazo-5-yl) or 3-[(3-phenylisoxazol-5-yl)-amino]substituted 4(3H)quinazolinone derivatives with antineoplastic activity. Pharmazie 54: 251-254.
14. Sami GA (2001): Synthesis of some new substituted quinazoline derivatives and their antimicrobial screening. SPJ 9: 72-84.
15. Taun PT, Edmund LE, Joseph PS, Brian MW, Michael AS, Hollis S, John MD, Martin AS, Themis J, Stephen JG, Dai QN, Paul B, Judy Y, Anurag S, Chan H, Saeed R, Xiujuan W, Rajeshwar S (2007): Structure activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors. Bioorg Med Chem Lett 17: 1312-1320.
16. Tobe M, Isobe Y, Tomizawa H, Nagasaki T, Obara F, Hayashi H (2003): Structure-activity relationships of 6-fluoroquinazolines: dual-acting compounds with inhibitory activities toward both TNF alpha production and T cell proliferation. Bioorg Med Chem 11: 609-616.
17. Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C, and the Linezolid CSSTI studygroup (2005): Linzolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 49: 2260-2266.
18. Yeung KS, Meanwell NA (2007): Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus. Infect Dis 7: 29-41.